Key result
Acetylsalicylic acid inhibited platelet aggregation with a lower IC50 in whole blood than in platelet-rich plasma, and required higher concentrations for half-maximal inhibition in females.
Why the study?
Does acetylsalicylic acid inhibit platelet aggregation differently in whole blood compared to platelet-rich plasma in male and female healthy volunteers?
Does acetylsalicylic acid inhibit platelet aggregation differently in whole blood compared to platelet-rich plasma in male and female healthy volunteers?
Answers are grounded in this paper and cite their sources.
Acetylsalicylic acid inhibits platelet aggregation more potently in whole blood than in platelet-rich plasma, with females requiring higher concentrations for half-maximal inhibition than males.
We have used the impedance aggregometer to study the in vitro effect of acetylsalicylic acid (ASA) in whole blood (WB) versus platelet-rich plasma (PRP) using blood samples from 24 male and 24 female healthy volunteers. IC50 was calculated from dose-response curves of ADP-, adrenaline-, collagen- and arachidonic acid-induced aggregation. ASA inhibited platelet aggregation in WB with a lower IC50 than PRP in male and female samples; the greater differences between WB and PRP inhibitory effect of ASA were in collagen- and archidonic acid-induced aggregation. A higher ASA concentration was needed in order to produce half maximal inhibition of platelet aggregation in female than in male samples with both WB and PRP method, except when ADP was used as the aggregating agent in PRP.
No takes yet. Share an insight, caveat, or question.
Cruz et al. (1986) studied healthy volunteers (n=48). acetylsalicylic acid (ASA) vs. platelet-rich plasma (PRP) was evaluated on IC50 of platelet aggregation. Acetylsalicylic acid inhibited platelet aggregation with a lower IC50 in whole blood than in platelet-rich plasma, and required higher concentrations for half-maximal inhibition in females.
Synapse has enriched 10 related papers. Consider them for comparative context: